V-Test(SH:688372) Sou Hu Cai Jing·2025-08-22 14:37Core Viewpoint - The company, Weicet Technology (688372), reported strong financial performance for the first half of 2025, with significant year-on-year growth in revenue and net profit, indicating robust operational momentum and capacity utilization. Financial Performance - The company's main revenue for the first half of 2025 reached 634 million yuan, a year-on-year increase of 47.53% [17] - The net profit attributable to shareholders was 101 million yuan, up 831.03% year-on-year [17] - The second quarter alone saw a revenue of 349 million yuan, reflecting a 41.68% increase year-on-year [17] Capacity Utilization - As of June 2025, the overall capacity utilization rate was approximately 90%, expected to approach full capacity by September [2] - The mid-range and Shanghai plants are operating at near full capacity, while there is still some room for improvement in high-end and Wuxi plants [2] Investment Projects - As of June 2025, the funding progress for the Wuxi and Nanjing projects reached 89.19% and 97.18%, respectively [3] Depreciation Impact - The fixed asset depreciation for the first half of 2025 was 207 million yuan, with equipment depreciation nearing 200 million yuan [4] - The total expected depreciation for the year is approximately 480 million yuan [4] Revenue Segmentation - The computing power business accounted for about 9% to 10% of total revenue in the first half of 2025, with expectations for this segment to double by year-end [5] - The revenue contribution from consumer electronics decreased from over 60% last year to over 50% in the first half of 2025, although absolute values increased [14] Future Outlook - The company anticipates continued revenue growth in both CP (Chip Production) and FT (Final Test) segments, with CP accounting for 58% and FT for 42% of revenue in the first half of 2025 [8] - The company plans capital expenditures of approximately 1.3 to 1.4 billion yuan for equipment this year [10] Market Position - The Wuxi plant is the largest testing base, contributing 51% of revenue in the first half of 2025, with Shanghai and Nanjing plants contributing 24% and 22%, respectively [13] - The company is strategically positioned to serve local clients in the Yangtze River Delta and Western regions through its various projects [15][16]